Namibia Pharmaceuticals and Healthcare Report Q4 2013: Business Monitor International Market Research Reports

Business Monitor International Market Research Reports Market Reports Online XML Feed

Startup Hiring: How to Hire the Best People Attract and retain the best people. 7 lectures from top founders and CEO's about how to hire for your startup! Sign up for $19. From our sponsors

Namibia Pharmaceuticals and Healthcare Report Q4 2013 Aug 7th 2013, 00:00 Price: $ 1295   BMI View: Increased longevity in developed markets translates into an increased demand for aged care healthcare services and medicines. However, in emerging markets such as Namibia, despite increased life expectancy, communicable diseases will remain a significant health burden over the next two decades - continuing to limit revenue earning opportunities for companies whose product portfolios contain medicines for the treatment of long-term diseases. Headline Expenditure Forecasts ? Pharmaceuticals: NAD2.20bn (US$268mn) in 2012 to NAD2.42bn (US$270mn) in 2013; +10.0% in local currency and +0.6%% in US dollar terms. ? Healthcare: NAD5.17bn (US$629mn) in 2012 to NAD5.55bn (US$619mn) in 2013; +7.5% in local currency and -1.7% in US dollar terms. ... Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/266777.html

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions